President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs.

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health agencies.

President Donald Trump recently paused updates from health agencies like the CDC and FDA. Here’s what South Carolina residents need to know about getting health information.

Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has instructed the heads of every federal health agency to stop public communication.

WASHINGTON — Donald Trump has promised sweeping actions in his second administration. The president-elect has outlined a wide-ranging agenda that blends traditional conservative approaches to taxes, regulation and cultural issues with a more populist bent on trade and a shift in America’s international role.

In the early days of his second term in office, Donald Trump has been cagey about where his administration will take abortion policy.

The U.S. Department of Health and Human Services has paused public communications until Feb. 1 as Trump appointees take control of health agencies.

Robert F. Kennedy Jr., Tulsi Gabbard and Kash Patel are expected to be grilled by senators during their confirmation hearings.

The Trump administration has put a freeze on many federal health agency communications with the public through at least the end of the month

President Donald ... administration. Viral social media posts claim that one of the orders revoked was one that lowered prescription drug costs for people on Medicare and Medicaid. Several VERIFY readers asked us if these posts are true. Did Trump rescind ...

Donald Trump has promised sweeping actions in ... Anti-abortion advocates continue to wage legal battles over the Food and Drug Administration’s approval of the drug as well as the agency's ...